Sex, aging and immunity in multiple sclerosis and experimental autoimmune encephalomyelitis: An intriguing interaction

Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system (CNS) with a profound neurodegenerative component early in the disease pathogenesis. Age is a factor with a well-described effect on the primary disease phenotype, namely, the relapsing-remitting vs. the primary progressive disease. Moreover, aging is a prominent factor contributing to the transition from relapsing-remitting MS (RRMS) to secondary progressive disease. However, sex also seems to, at least in part, dictate disease phenotype and evolution, as evidenced in humans and in animal models of the disease. Sex-specific gene expression profiles have recently elucidated an association with differential immunological signatures in the context of experimental disease. This review aims to summarize current knowledge stemming from experimental autoimmune encephalomyelitis (EAE) models regarding the effects of sex, either independently or as a factor combined with aging, on disease phenotype, with relevance to the immune system and the CNS.

[1]  M. Jagodic,et al.  Epigenetic clock indicates accelerated aging in glial cells of progressive multiple sclerosis patients , 2022, Frontiers in Aging Neuroscience.

[2]  M. Magyari,et al.  Quantitative effect of sex on disease activity and disability accumulation in multiple sclerosis , 2022, Journal of Neurology, Neurosurgery, and Psychiatry.

[3]  M. Lynch Exploring Sex-Related Differences in Microglia May Be a Game-Changer in Precision Medicine , 2022, Frontiers in Aging Neuroscience.

[4]  D. Conen,et al.  Serum neurofilament light chain for individual prognostication of disease activity in people with multiple sclerosis: a retrospective modelling and validation study , 2022, The Lancet Neurology.

[5]  Ludmila V. Danilova,et al.  Genome-wide DNA methylation profiling identifies epigenetic changes in CD4+ and CD14+ cells of multiple sclerosis patients. , 2022, Multiple sclerosis and related disorders.

[6]  I. Sack,et al.  Sexual Dimorphism in Extracellular Matrix Composition and Viscoelasticity of the Healthy and Inflamed Mouse Brain , 2021, Biology.

[7]  S. Hauser,et al.  Specific hypomethylation programs underpin B cell activation in early multiple sclerosis , 2021, Proceedings of the National Academy of Sciences of the United States of America.

[8]  N. Grigoriadis,et al.  Lumbar spine intrathecal transplantation of neural precursor cells promotes oligodendrocyte proliferation in hot spots of chronic demyelination , 2021, Brain pathology.

[9]  Maxim N. Artyomov,et al.  Immune ageing at single-cell resolution , 2021, Nature Reviews Immunology.

[10]  Muhammad Umair,et al.  Biological Sex As a Critical Variable in CD4+ Effector T Cell Function in Preclinical Models of Multiple Sclerosis , 2021, Antioxidants & redox signaling.

[11]  D. Booth,et al.  Gender and the Sex Hormone Estradiol Affect Multiple Sclerosis Risk Gene Expression in Epstein-Barr Virus-Infected B Cells , 2021, Frontiers in Immunology.

[12]  R. Bove,et al.  Effects of Menopause in Women With Multiple Sclerosis: An Evidence-Based Review , 2021, Frontiers in Neurology.

[13]  A. Clyne,et al.  Sex differences in the blood–brain barrier and neurodegenerative diseases , 2021, APL bioengineering.

[14]  A. Vandenbark,et al.  Sex differences in EAE reveal common and distinct cellular and molecular components. , 2020, Cellular immunology.

[15]  A. Arnold,et al.  Four Core Genotypes and XY* mouse models: Update on impact on SABV research , 2020, Neuroscience & Biobehavioral Reviews.

[16]  Z. Illés,et al.  Mechanisms of sex hormones in autoimmunity: focus on EAE , 2020, Biology of sex differences.

[17]  M. Acosta-Martínez Shaping Microglial Phenotypes Through Estrogen Receptors: Relevance to Sex-Specific Neuroinflammatory Responses to Brain Injury and Disease , 2020, The Journal of Pharmacology and Experimental Therapeutics.

[18]  K. Blomgren,et al.  Sex-Specific Effects of Microglia-Like Cell Engraftment during Experimental Autoimmune Encephalomyelitis , 2020, International journal of molecular sciences.

[19]  K. Kosik,et al.  Microglial microRNAs mediate sex-specific responses to tau pathology , 2019, Nature Neuroscience.

[20]  M. Sofroniew,et al.  The astrocyte transcriptome in EAE optic neuritis shows complement activation and reveals a sex difference in astrocytic C3 expression , 2019, Scientific Reports.

[21]  N. Lefèvre,et al.  The Number of X Chromosomes Influences Inflammatory Cytokine Production Following Toll-Like Receptor Stimulation , 2019, Front. Immunol..

[22]  Tuan Leng Tay,et al.  Single-cell profiling identifies myeloid cell subsets with distinct fates during neuroinflammation , 2019, Science.

[23]  C. Kamm,et al.  Age‐dependent variation of female preponderance across different phenotypes of multiple sclerosis: A retrospective cross‐sectional study , 2018, CNS neuroscience & therapeutics.

[24]  R. Scott,et al.  Genome-wide DNA methylation changes in CD19+ B cells from relapsing-remitting multiple sclerosis patients , 2018, Scientific Reports.

[25]  Mark T. W. Ebbert,et al.  Microglial translational profiling reveals a convergent APOE pathway from aging, amyloid, and tau , 2018, The Journal of experimental medicine.

[26]  B. Joseph,et al.  Epigenetics Control Microglia Plasticity , 2018, Front. Cell. Neurosci..

[27]  K. Lenz,et al.  Microglia and Beyond: Innate Immune Cells As Regulators of Brain Development and Behavioral Function , 2018, Front. Immunol..

[28]  M. Staufenbiel,et al.  Innate immune memory in the brain shapes neurological disease hallmarks , 2018, Nature.

[29]  R. Voskuhl,et al.  Sex chromosome contributions to sex differences in multiple sclerosis susceptibility and progression , 2018, Multiple sclerosis.

[30]  D. Absher,et al.  Hypermethylation of MIR21 in CD4+ T cells from patients with relapsing-remitting multiple sclerosis associates with lower miRNA-21 levels and concomitant up-regulation of its target genes , 2017, Multiple sclerosis.

[31]  R. Gredilla,et al.  Role of Estrogen and Other Sex Hormones in Brain Aging. Neuroprotection and DNA Repair , 2017, Front. Aging Neurosci..

[32]  Je-Min Choi,et al.  Sex-specific regulation of immune responses by PPARs , 2017, Experimental &Molecular Medicine.

[33]  M. Jagodic,et al.  Epigenetic research in multiple sclerosis: progress, challenges, and opportunities. , 2017, Physiological genomics.

[34]  W. Freeman,et al.  Sexually divergent induction of microglial-associated neuroinflammation with hippocampal aging , 2017, Journal of Neuroinflammation.

[35]  A. Vandenbark,et al.  Estrogen protects both sexes against EAE by promoting common regulatory cell subtypes independent of endogenous estrogen , 2017, Metabolic Brain Disease.

[36]  E. Vegeto,et al.  Influence of Estrogen Modulation on Glia Activation in a Murine Model of Parkinson's Disease , 2017, Front. Neurosci..

[37]  D. Bourdette,et al.  Sex-dependent treatment of chronic EAE with partial MHC class II constructs , 2017, Journal of Neuroinflammation.

[38]  J. Lanciego,et al.  Brain Renin-Angiotensin System and Microglial Polarization: Implications for Aging and Neurodegeneration , 2017, Front. Aging Neurosci..

[39]  S. Amor,et al.  Multiple sclerosis animal models: a clinical and histopathological perspective , 2017, Brain pathology.

[40]  J. Nissen Microglial Function across the Spectrum of Age and Gender , 2017, International journal of molecular sciences.

[41]  Bruce S. McEwen,et al.  Sex in the brain: hormones and sex differences , 2016, Dialogues in clinical neuroscience.

[42]  H. Lassmann,et al.  Multiple sclerosis: experimental models and reality , 2016, Acta Neuropathologica.

[43]  S. Klein,et al.  Sex differences in immune responses , 2016, Nature Reviews Immunology.

[44]  H. Lassmann,et al.  Neurodegeneration in multiple sclerosis and neuromyelitis optica , 2016, Journal of Neurology, Neurosurgery & Psychiatry.

[45]  Z. Liposits,et al.  Long-Term Estrogen Receptor Beta Agonist Treatment Modifies the Hippocampal Transcriptome in Middle-Aged Ovariectomized Rats , 2016, Front. Cell. Neurosci..

[46]  P. D. De Jager,et al.  Exploration of changes in disability after menopause in a longitudinal multiple sclerosis cohort , 2016, Multiple sclerosis.

[47]  A. Maggi,et al.  Estrogens, Neuroinflammation, and Neurodegeneration. , 2016, Endocrine reviews.

[48]  J. Kieswich,et al.  Estrogen protects the blood–brain barrier from inflammation-induced disruption and increased lymphocyte trafficking , 2016, Brain, Behavior, and Immunity.

[49]  R. Clements,et al.  The neuronal metabolite NAA regulates histone H3 methylation in oligodendrocytes and myelin lipid composition , 2016, Experimental Brain Research.

[50]  K. Kleopa,et al.  Connexin43 and connexin47 alterations after neural precursor cells transplantation in experimental autoimmune encephalomyelitis , 2015, Glia.

[51]  S. Zheng,et al.  FOXP3+ Treg Cells and Gender Bias in Autoimmune Diseases , 2015, Front. Immunol..

[52]  A. Vandenbark,et al.  HLA-DRα1-mMOG-35-55 treatment of experimental autoimmune encephalomyelitis reduces CNS inflammation, enhances M2 macrophage frequency, and promotes neuroprotection , 2015, Journal of Neuroinflammation.

[53]  Pierre Grammond,et al.  Male Sex Is Independently Associated with Faster Disability Accumulation in Relapse-Onset MS but Not in Primary Progressive MS , 2015, PloS one.

[54]  Z. Liposits,et al.  Hippocampal Gene Expression Is Highly Responsive to Estradiol Replacement in Middle-Aged Female Rats. , 2015, Endocrinology.

[55]  A. Arnold,et al.  Four Core Genotypes mouse model: localization of the Sry transgene and bioassay for testicular hormone levels , 2015, BMC Research Notes.

[56]  D. Kosec,et al.  Ovarian hormone level alterations during rat post-reproductive life-span influence CD8 + T-cell homeostasis , 2015, Experimental biology and medicine.

[57]  L. Tan,et al.  TYROBP in Alzheimer’s Disease , 2015, Molecular Neurobiology.

[58]  Z. Liposits,et al.  Estradiol and isotype-selective estrogen receptor agonists modulate the mesocortical dopaminergic system in gonadectomized female rats , 2014, Brain Research.

[59]  P. Bonthuis,et al.  Mouse model systems to study sex chromosome genes and behavior: Relevance to humans , 2014, Frontiers in Neuroendocrinology.

[60]  R. Scott,et al.  Methylation differences at the HLA-DRB1 locus in CD4+ T-Cells are associated with multiple sclerosis , 2014, Multiple sclerosis.

[61]  T. Olsson,et al.  Smoking and Risk of Multiple Sclerosis: Evidence of Modification by NAT1 Variants , 2014, Epidemiology.

[62]  Cheng Luo,et al.  Active, phosphorylated fingolimod inhibits histone deacetylases and facilitates fear extinction memory , 2014, Nature Neuroscience.

[63]  J. Hillert,et al.  New data identify an increasing sex ratio of multiple sclerosis in Sweden , 2014, Multiple sclerosis.

[64]  T. Owens,et al.  MOG extracellular domain (p1–125) triggers elevated frequency of CXCR3+ CD4+ Th1 cells in the CNS of mice and induces greater incidence of severe EAE , 2014, Multiple sclerosis.

[65]  A. Arnold,et al.  XY sex chromosome complement, compared with XX, in the CNS confers greater neurodegeneration during experimental autoimmune encephalomyelitis , 2014, Proceedings of the National Academy of Sciences.

[66]  Stephen D Miller,et al.  The experimental autoimmune encephalomyelitis (EAE) model of MS: utility for understanding disease pathophysiology and treatment. , 2014, Handbook of clinical neurology.

[67]  S. Chandran,et al.  Neurodegeneration progresses despite complete elimination of clinical relapses in a mouse model of multiple sclerosis , 2013, Acta Neuropathologica Communications.

[68]  J. Lechner-Scott,et al.  Sex as a determinant of relapse incidence and progressive course of multiple sclerosis. , 2013, Brain : a journal of neurology.

[69]  A. Ramasamy,et al.  Widespread sex differences in gene expression and splicing in the adult human brain , 2013, Nature Communications.

[70]  Toshiro K. Ohsumi,et al.  The Microglial Sensome Revealed by Direct RNA Sequencing , 2013, Nature Neuroscience.

[71]  M. Pirinen,et al.  Analysis of immune-related loci identifies 48 new susceptibility variants for multiple sclerosis , 2013, Nature Genetics.

[72]  C. Wolfson,et al.  Incidence and prevalence of multiple sclerosis in Europe: a systematic review , 2013, BMC Neurology.

[73]  Manuel Serrano,et al.  The Hallmarks of Aging , 2013, Cell.

[74]  Maja O’Connor LONGITUDINAL STUDY , 2013 .

[75]  E. Celius,et al.  Sex ratio of multiple sclerosis in persons born from 1930 to 1979 and its relation to latitude in Norway , 2013, Journal of Neurology.

[76]  C. Cotman,et al.  Menopause leads to elevated expression of macrophage-associated genes in the aging frontal cortex: rat and human studies identify strikingly similar changes , 2012, Journal of Neuroinflammation.

[77]  Pierre Grammond,et al.  Geographical Variations in Sex Ratio Trends over Time in Multiple Sclerosis , 2012, PloS one.

[78]  O. Touloumi,et al.  Time Course and Spatial Profile of Nogo-A Expression in Experimental Autoimmune Encephalomyelitis in C57BL/6 Mice , 2012, Journal of neuropathology and experimental neurology.

[79]  T. O'Dell,et al.  Therapeutic Testosterone Administration Preserves Excitatory Synaptic Transmission in the Hippocampus during Autoimmune Demyelinating Disease , 2012, The Journal of Neuroscience.

[80]  R. Ransohoff,et al.  Animal models of multiple sclerosis: the good, the bad and the bottom line , 2012, Nature Neuroscience.

[81]  A. Maggi,et al.  A lack of ovarian function increases neuroinflammation in aged mice. , 2012, Endocrinology.

[82]  E. Mohammadi,et al.  Barriers and facilitators related to the implementation of a physiological track and trigger system: A systematic review of the qualitative evidence , 2017, International journal for quality in health care : journal of the International Society for Quality in Health Care.

[83]  C. Pike,et al.  Sex hormones, aging, and Alzheimer's disease. , 2012, Frontiers in bioscience.

[84]  C. Constantinescu,et al.  Experimental autoimmune encephalomyelitis (EAE) as a model for multiple sclerosis (MS) , 2011, British journal of pharmacology.

[85]  Simon C. Potter,et al.  Genetic risk and a primary role for cell-mediated immune mechanisms in multiple sclerosis , 2011, Nature.

[86]  H. Soininen,et al.  Astrocytes in the aging brain express characteristics of senescence‐associated secretory phenotype , 2011, The European journal of neuroscience.

[87]  R. Cardarelli,et al.  Significant differences in global genomic DNA methylation by gender and race/ethnicity in peripheral blood , 2011, Epigenetics.

[88]  T. Olsson,et al.  Smoking and two human leukocyte antigen genes interact to increase the risk for multiple sclerosis. , 2011, Brain : a journal of neurology.

[89]  F. Sohrabji,et al.  Reproductive age modulates the impact of focal ischemia on the forebrain as well as the effects of estrogen treatment in female rats , 2010, Neurobiology of Aging.

[90]  P. Rieckmann,et al.  The natural history of secondary progressive multiple sclerosis , 2010, Journal of Neurology, Neurosurgery & Psychiatry.

[91]  P. Sørensen,et al.  The changing demographic pattern of multiple sclerosis epidemiology , 2010, The Lancet Neurology.

[92]  J de Lange,et al.  An evidence-based review? , 2010, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[93]  G. Krishnamoorthy,et al.  Autoimmune disease : Multiple sclerosis EAE : An immunologist ’ s magic eye , 2009 .

[94]  K. Berer,et al.  Spontaneous relapsing-remitting EAE in the SJL/J mouse: MOG-reactive transgenic T cells recruit endogenous MOG-specific B cells , 2009, The Journal of experimental medicine.

[95]  A. Arnold,et al.  What does the “four core genotypes” mouse model tell us about sex differences in the brain and other tissues? , 2009, Frontiers in Neuroendocrinology.

[96]  Carl W. Cotman,et al.  Gene expression changes in the course of normal brain aging are sexually dimorphic , 2008, Proceedings of the National Academy of Sciences.

[97]  R. Franklin,et al.  Age-dependent epigenetic control of differentiation inhibitors is critical for remyelination efficiency , 2008, Nature Neuroscience.

[98]  A. Arnold,et al.  A role for sex chromosome complement in the female bias in autoimmune disease , 2008, The Journal of experimental medicine.

[99]  M. Kelly,et al.  GPR30 contributes to estrogen-induced thymic atrophy. , 2008, Molecular endocrinology.

[100]  L. Stoltze,et al.  Higher frequency of regulatory T cells in the elderly and increased suppressive activity in neurodegeneration , 2007, Journal of Neuroimmunology.

[101]  C. Benoist,et al.  A decade of AIRE , 2007, Nature Reviews Immunology.

[102]  G. Kersh,et al.  Murine pregnancy leads to reduced proliferation of maternal thymocytes and decreased thymic emigration , 2007, Immunology.

[103]  E. Bettelli Building Different Mouse Models for Human MS , 2007, Annals of the New York Academy of Sciences.

[104]  A. Vandenbark,et al.  Treg suppressive activity involves estrogen-dependent expression of programmed death-1 (PD-1). , 2007, International immunology.

[105]  B. Trapp,et al.  Evidence for synaptic stripping by cortical microglia , 2007, Glia.

[106]  S. Youssef,et al.  Peroxisome proliferator–activated receptor (PPAR)α expression in T cells mediates gender differences in development of T cell–mediated autoimmunity , 2007, The Journal of experimental medicine.

[107]  J. Bell,et al.  Parental transmission of HLA-DRB1*15 in multiple sclerosis , 2007, Human Genetics.

[108]  J. Goverman,et al.  Passive induction of experimental allergic encephalomyelitis , 2006, Nature Protocols.

[109]  W. Valdar,et al.  Sex ratio of multiple sclerosis in Canada: a longitudinal study , 2006, The Lancet Neurology.

[110]  D. Bourdette,et al.  Antigen‐Specific Therapy Promotes Repair of Myelin and Axonal Damage in Established EAE , 2006, Journal of neurochemistry.

[111]  Lawrence Steinman,et al.  How to successfully apply animal studies in experimental allergic encephalomyelitis to research on multiple sclerosis , 2006, Annals of neurology.

[112]  Rhonda R. Voskuhl,et al.  Treatment with an Estrogen Receptor α Ligand Is Neuroprotective in Experimental Autoimmune Encephalomyelitis , 2006, The Journal of Neuroscience.

[113]  G. Kersh,et al.  Estrogen Induces Thymic Atrophy by Eliminating Early Thymic Progenitors and Inhibiting Proliferation of β-Selected Thymocytes1 , 2006, The Journal of Immunology.

[114]  J. Zachary,et al.  Evidence that the Y chromosome influences autoimmune disease in male and female mice. , 2006, Proceedings of the National Academy of Sciences of the United States of America.

[115]  J. Aarseth,et al.  A 50-year follow-up of the incidence of multiple sclerosis in Hordaland County, Norway , 2006, Neurology.

[116]  L. Kappos,et al.  Predictors of relapse rate in MS clinical trials , 2005, Neurology.

[117]  N. Risch,et al.  Parent-of-origin effect in multiple sclerosis: observations in half-siblings , 2004, The Lancet.

[118]  C. Whitacre,et al.  Sex differences in experimental autoimmune encephalomyelitis in multiple murine strains , 2004, Journal of Neuroimmunology.

[119]  R. Voskuhl,et al.  Estriol treatment ameliorates disease in males with experimental autoimmune encephalomyelitis: implications for multiple sclerosis , 2004, Journal of Neuroimmunology.

[120]  S. Kovats,et al.  Estrogen Preferentially Promotes the Differentiation of CD11c+ CD11bintermediate Dendritic Cells from Bone Marrow Precursors1 , 2004, The Journal of Immunology.

[121]  V. Kuchroo,et al.  Minireview: Autoimmune responses to myelin proteolipid protein , 1994, Neurochemical Research.

[122]  D. Lubahn,et al.  Estrogen Receptor α Mediates Estrogen’s Immune Protection in Autoimmune Disease , 2003, The Journal of Immunology.

[123]  N. Risch,et al.  Twin concordance and sibling recurrence rates in multiple sclerosis , 2003, Proceedings of the National Academy of Sciences of the United States of America.

[124]  C. Teuscher,et al.  The Protective Effect of 17 (cid:1) -Estradiol on Experimental Autoimmune Encephalomyelitis Is Mediated through Estrogen Receptor- (cid:2) , 2003 .

[125]  D. B. Williams,et al.  Progressive increase in incidence and prevalence of multiple sclerosis in Newcastle, Australia: a 35-year study , 2003, Journal of the Neurological Sciences.

[126]  A. Vandenbark,et al.  Oral Feeding with Ethinyl Estradiol Suppresses and Treats Experimental Autoimmune Encephalomyelitis in SJL Mice and Inhibits the Recruitment of Inflammatory Cells into the Central Nervous System 1 , 2003, The Journal of Immunology.

[127]  M. Nagarkatti,et al.  Role of death receptor pathway in estradiol-induced T-cell apoptosis in vivo. , 2002, Toxicological sciences : an official journal of the Society of Toxicology.

[128]  J. Dwyer,et al.  Estrogen inhibition of EAE involves effects on dendritic cell function , 2002, Journal of neuroscience research.

[129]  K. Dahlman-Wright,et al.  Estrogen receptor specificity for the effects of estrogen in ovariectomized mice. , 2002, The Journal of endocrinology.

[130]  R. Voskuhl,et al.  Testosterone Acts Directly on CD4+ T Lymphocytes to Increase IL-10 Production1 , 2001, The Journal of Immunology.

[131]  H. Offner,et al.  Estrogen Treatment Down-Regulates TNF-α Production and Reduces the Severity of Experimental Autoimmune Encephalomyelitis in Cytokine Knockout Mice1 , 2001, The Journal of Immunology.

[132]  M. Nagarkatti,et al.  Evidence for estradiol-induced apoptosis and dysregulated T cell maturation in the thymus. , 2001, Toxicology.

[133]  A. Vandenbark,et al.  Low-Dose Estrogen Therapy Ameliorates Experimental Autoimmune Encephalomyelitis in Two Different Inbred Mouse Strains1 , 2001, The Journal of Immunology.

[134]  M. Mattson,et al.  Antiinflammatory effects of estrogen on microglial activation. , 2000, Endocrinology.

[135]  L. Garcia-Segura,et al.  Role of astroglia in estrogen regulation of synaptic plasticity and brain repair. , 1999, Journal of neurobiology.

[136]  R. Voskuhl,et al.  Estriol ameliorates autoimmune demyelinating disease , 1999, Neurology.

[137]  R. Doerge,et al.  Genetic analysis of disease subtypes and sexual dimorphisms in mouse experimental allergic encephalomyelitis (EAE): relapsing/remitting and monophasic remitting/nonrelapsing EAE are immunogenetically distinct. , 1999, Journal of immunology.

[138]  Caroline C. Whitacre,et al.  A Gender Gap in Autoimmunity , 1999, Science.

[139]  A. Vandenbark,et al.  Androgens alter the cytokine profile and reduce encephalitogenicity of myelin-reactive T cells. , 1999, Journal of immunology.

[140]  G. Adamus,et al.  Gonadal hormones influence the immune response to PLP 139–151 and the clinical course of relapsing experimental autoimmmune encephalomyelitis , 1998, Journal of Neuroimmunology.

[141]  R. Voskuhl,et al.  Testosterone therapy ameliorates experimental autoimmune encephalomyelitis and induces a T helper 2 bias in the autoantigen-specific T lymphocyte response. , 1997, Journal of immunology.

[142]  R. Miller,et al.  Localization of the mouse gene releasing sex-limited expression of Slp. , 1996, Proceedings of the National Academy of Sciences of the United States of America.

[143]  A. Ben-nun,et al.  A myelin oligodendrocyte glycoprotein peptide induces typical chronic experimental autoimmune encephalomyelitis in H‐2b mice: Fine specificity and T cell receptor Vβ expression of encephalitogenic T cells , 1995, European journal of immunology.

[144]  K. Medina,et al.  Suppression of B lymphopoiesis during normal pregnancy , 1993, The Journal of experimental medicine.

[145]  S. Miller,et al.  Induction of active and adoptive relapsing experimental autoimmune encephalomyelitis (EAE) using an encephalitogenic epitope of proteolipid protein , 1992, Journal of Neuroimmunology.

[146]  B. Greenstein,et al.  Effects of various steroids on the thymus, spleen, ventral prostate and seminal vesicles in old orchidectomized rats. , 1987, The Journal of endocrinology.